Actively Recruiting
Lateral Plantar Artery Embolization to Treat Chronic Heel Pain Due to Plantar Fasciitis A Pilot Study to Assess Feasibility
Led by Joint & Vascular Institute · Updated on 2026-02-09
10
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating if lateral plantar artery embolization using Lipiodol can safely and effectively treat chronic heel pain caused by plantar fasciitis in adults aged 25 to 80. This pilot study aims to determine whether this minimally invasive procedure can reduce pain over 12 months and assess the safety by monitoring serious medical problems or adverse events related to the device. Participants will undergo a procedure where a doctor inserts a small tube (catheter) to inject Lipiodol, a temporary blocking agent, into specific blood vessels in the foot. The procedure targets branches of the lateral plantar artery associated with increased blood vessel growth linked to chronic plantar fasciitis. The injection is guided by imaging and uses up to 5 mL of Lipiodol to reduce pain and inflammation. After the procedure, participants will receive a phone call the next day to check for early side effects. They will then take part in four telehealth follow-up visits at 1, 3, 6, and 12 months, during which they will complete pain surveys using the Visual Analog Scale (VAS) and report any changes in other treatments or medications. Researchers will monitor pain changes and safety outcomes throughout the year-long study.
CONDITIONS
Brief Title
Lateral Plantar Artery Embolization For Plantar Fasciitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 25 years or older
- Provide written informed consent
- Diagnosis of plantar fasciitis not improved after 3 months of conservative treatment
- Self-reported heel pain of 4 or higher on the Visual Analog Scale (VAS)
- Not a candidate for surgery or seeking to avoid surgery
You will not qualify if you...
- Heel pain caused by acute fracture, recent injury, inflammatory conditions, muscle or ligament injury, or bone density issues
- Steroid injection in the heel within 90 days before the procedure
- Known severe allergy to Lipiodol or iodinated contrast media
- Diagnosis of peripheral arterial disease in the lower limbs
- Pregnancy or breastfeeding
- Currently on anticoagulation or have irreversible blood clotting disorders
- Kidney function with GFR less than 45 or serum creatinine over 2.0 mg/dl
- Type 1 Diabetes Mellitus
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 1 day
Participants receive a transcatheter arterial embolization of the lateral plantar artery branches using a device to reduce pain and inflammation associated with plantar fasciitis.
1 procedure visit (in-person)
Duration - 12 months
Participants are monitored for pain changes and safety outcomes following the embolization procedure.
Follow-up visits over 12 months
Trial Site Locations
Total: 1 location
1
Joint and Vascular Institute
Libertyville, Illinois, United States, 60048
Actively Recruiting
Research Team
L
Layth Alkhani
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DEVICE_FEASIBILITY
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here